|
1
|
McLaughlin JK, Lipworth L and Tarone RE:
Epidemiologic aspects of renal cell carcinoma. Semin Oncol.
33:527–533. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Qin C, Sun LJ, Cui L, Cao Q, Zhu J, Li P,
Zhang GM, Mao X, Shao PF, Wang ML, et al: Application of the
revised tumour node metastasis (TNM) staging system of clear cell
renal cell carcinoma in eastern China: Advantages and limitations.
Asian J Androl. 15:550–557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cairns P: Renal cell carcinoma. Cancer
Biomark. 9:461–473. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cohen HT and McGovern FJ: Renal-cell
carcinoma. N Engl J Med. 353:2477–2490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jenne DE, Reimann H, Nezu J, Friedel W,
Loff S, Jeschke R, Müller O, Back W and Zimmer M: Peutz-Jeghers
syndrome is caused by mutations in a novel serine threonine kinase.
Nat Genet. 18:38–43. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao RX and Xu ZX: Targeting the LKB1
tumor suppressor. Curr Drug Targets. 15:32–52. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sanchez-Cespedes M, Parrella P, Esteller
M, Nomoto S, Trink B, Engles JM, Westra WH, Herman JG and Sidransky
D: Inactivation of LKB1/STK11 is a common event in adenocarcinomas
of the lung. Cancer Res. 62:3659–3662. 2002.PubMed/NCBI
|
|
8
|
Kim CJ, Cho YG, Park JY, Kim TY, Lee JH,
Kim HS, Lee JW, Song YH, Nam SW, Lee SH, et al: Genetic analysis of
the LKB1/STK11 gene in hepatocellular carcinomas. Eur J Cancer.
40:136–141. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bignell GR, Barfoot R, Seal S, Collins N,
Warren W and Stratton MR: Low frequency of somatic mutations in the
LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer. Cancer
Res. 58:1384–1386. 1998.PubMed/NCBI
|
|
10
|
Nakau M, Miyoshi H, Seldin MF, Imamura M,
Oshima M and Taketo MM: Hepatocellular carcinoma caused by loss of
heterozygosity in Lkb1 gene knockout mice. Cancer Res.
62:4549–4553. 2002.PubMed/NCBI
|
|
11
|
Robinson J, Nye E, Stamp G and Silver A:
Osteogenic tumours in Lkb1-deficient mice. Exp Mol Pathol.
85:223–226. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Su GH, Hruban RH, Bansal RK, Bova GS, Tang
DJ, Shekher MC, Westerman AM, Entius MM, Goggins M, Yeo CJ and Kern
SE: Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers
gene in pancreatic and biliary cancers. Am J Pathol. 154:1835–1840.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Avizienyte E, Roth S, Loukola A, Hemminki
A, Lothe RA, Stenwig AE, Fosså SD, Salovaara R and Aaltonen LA:
Somatic mutations in LKB1 are rare in sporadic colorectal and
testicular tumors. Cancer Res. 58:2087–2090. 1998.PubMed/NCBI
|
|
14
|
Koivunen JP, Kim J, Lee J, Rogers AM, Park
JO, Zhao X, Naoki K, Okamoto I, Nakagawa K, Yeap BY, et al:
Mutations in the LKB1 tumour suppressor are frequently detected in
tumours from Caucasian but not Asian lung cancer patients. Br J
Cancer. 99:245–252. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Avizienyte E, Loukola A, Roth S, Hemminki
A, Tarkkanen M, Salovaara R, Arola J, Bützow R,
Husgafvel-Pursiainen K, Kokkola A, et al: LKB1 somatic mutations in
sporadic tumors. Am J Pathol. 154:677–681. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yalniz Z, Tigli H, Tigli H, Sanli O, Dalay
N and Buyru N: Novel mutations and role of the LKB1 gene as a tumor
suppressor in renal cell carcinoma. Tumour Biol. 35:12361–12368.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fenton H, Carlile B, Montgomery EA,
Carraway H, Herman J, Sahin F, Su GH and Argani P: LKB1 protein
expression in human breast cancer. Appl Immunohistochem Mol
Morphol. 14:146–153. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duivenvoorden WC, Beatty LK, Lhotak S,
Hill B, Mak I, Paulin G, Gallino D, Popovic S, Austin RC and
Pinthus JH: Underexpression of tumour suppressor LKB1 in clear cell
renal cell carcinoma is common and confers growth advantage in
vitro and in vivo. Br J Cancer. 108:327–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gan RY and Li HB: Recent progress on liver
kinase B1 (LKB1): Expression, regulation, downstream signaling and
cancer suppressive function. Int J Mol Sci. 15:16698–16718. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Trojan J, Brieger A, Raedle J, Esteller M
and Zeuzem S: 5′-CpG island methylation of the LKB1/STK11 promoter
and allelic loss at chromosome 19p13.3 in sporadic colorectal
cancer. Gut. 47:272–276. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee SM, Choi JE, Na YK, Lee EJ, Lee WK,
Choi YY, Yoon GS, Jeon HS, Kim DS and Park JY: Genetic and
epigenetic alterations of the LKB1 gene and their associations with
mutations in TP53 and EGFR pathway genes in Korean non-small cell
lung cancers. Lung Cancer. 81:194–199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Esteller M, Avizienyte E, Corn PG, Lothe
RA, Baylin SB, Aaltonen LA and Herman JG: Epigenetic inactivation
of LKB1 in primary tumors associated with the Peutz-Jeghers
syndrome. Oncogene. 19:164–168. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sato N, Rosty C, Jansen M, Fukushima N,
Ueki T, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH and
Goggins M: STK11/LKB1 Peutz-Jeghers gene inactivation in
intraductal papillary-mucinous neoplasms of the pancreas. Am J
Pathol. 159:2017–2022. 2001. View Article : Google Scholar : PubMed/NCBI
|
